Published: 28 Nov 2011 |
By bas.zap|
Last updated: 23 Jan 2012
The seven transmembrane-spanning G protein-coupled receptors (GPCRs) are the largest superfamily of receptors in the human genome, are involved in virtually all physiological processes and represent the targets for at least 30% of all current medicines.
Recent years have witnessed the coalescing of a number of important paradigms, including ligand-biased signaling, allosteric modulation and receptor dimerization, with substantial advances in structural determination, chemical biology and in vivo approaches to studying GPCR function.
These developments will undoubtedly have a profound impact on future approaches to GPCR-based drug discovery. This meeting will focus on the interplay between these developments, and how they can be exploited to advance the translational application of cutting-edge GPCR-based research.
View version history Location:Banff Aspen Lodge, Canada Start: Friday 17 February 2012, 10:00 AM - 05:00 PM End: Wednesday 22 February 2012, 05:00 PM Duration 6 day(s) Planning: confirmed Ended: 92 days ago